A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition
2024 · npj Precision Oncology · 4 citations
https://doi.org/10.1038/s41698-023-00490-w
D
Daniel S. Lenchner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Daniel S. Lenchner is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat